You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Suppliers and packagers for generic pharmaceutical drug: estradiol; norethindrone acetate


✉ Email this page to a colleague

« Back to Dashboard


estradiol; norethindrone acetate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Noven Pharms Inc COMBIPATCH estradiol; norethindrone acetate FILM, EXTENDED RELEASE;TRANSDERMAL 020870 NDA Noven Therapeutics, LLC 68968-0514-8 8 POUCH in 1 CARTON (68968-0514-8) / 1 PATCH in 1 POUCH / 3.5 d in 1 PATCH 1998-08-07
Noven Pharms Inc COMBIPATCH estradiol; norethindrone acetate FILM, EXTENDED RELEASE;TRANSDERMAL 020870 NDA Noven Therapeutics, LLC 68968-0525-8 8 POUCH in 1 CARTON (68968-0525-8) / 1 PATCH in 1 POUCH / 3.5 d in 1 PATCH 1998-08-07
Amneal ACTIVELLA estradiol; norethindrone acetate TABLET;ORAL 020907 NDA Amneal Pharmaceuticals LLC 60846-231-01 1 BLISTER PACK in 1 CARTON (60846-231-01) / 28 TABLET, FILM COATED in 1 BLISTER PACK 2019-05-01
Amneal ACTIVELLA estradiol; norethindrone acetate TABLET;ORAL 020907 NDA Amneal Pharmaceuticals LLC 60846-232-01 1 BLISTER PACK in 1 CARTON (60846-232-01) / 28 TABLET, FILM COATED in 1 BLISTER PACK 2019-05-01
Amneal ACTIVELLA estradiol; norethindrone acetate TABLET;ORAL 020907 NDA AUTHORIZED GENERIC Amneal Pharmaceuticals NY LLC 69238-1251-8 5 CARTON in 1 CELLO PACK (69238-1251-8) / 1 DIALPACK in 1 CARTON (69238-1251-6) / 28 TABLET, FILM COATED in 1 DIALPACK 2014-10-01
Amneal ACTIVELLA estradiol; norethindrone acetate TABLET;ORAL 020907 NDA AUTHORIZED GENERIC Amneal Pharmaceuticals NY LLC 69238-1252-8 5 CARTON in 1 CELLO PACK (69238-1252-8) / 1 DIALPACK in 1 CARTON (69238-1252-6) / 28 TABLET, FILM COATED in 1 DIALPACK 2014-10-01
Amneal ACTIVELLA estradiol; norethindrone acetate TABLET;ORAL 020907 NDA Amneal Pharmaceuticals NY LLC 69238-1609-6 1 BLISTER PACK in 1 CARTON (69238-1609-6) / 28 TABLET, FILM COATED in 1 BLISTER PACK 2019-01-07
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Estradiol and Norethindrone Acetate

Last updated: July 28, 2025

Introduction

The demand for hormone replacement therapies and contraceptive formulations continues to grow globally, positioning estrogen and progestin components like estradiol and norethindrone acetate as critical ingredients in the pharmaceutical landscape. These compounds serve pivotal roles in treatments related to menopausal symptoms, contraception, and hormone deficiency management. Reliable suppliers of high-quality estradiol and norethindrone acetate are essential for pharmaceutical manufacturers, regulatory compliance, and patient safety. This article provides an in-depth overview of leading suppliers, sourcing trends, and considerations for stakeholders seeking pharmaceutical-grade hormones.

Overview of Estradiol and Norethindrone Acetate

Estradiol

Estradiol is a natural estrogenic hormone and a cornerstone in hormone replacement therapy (HRT). Its pharmaceutical applications include formulations for menopausal symptom alleviation, osteoporosis prevention, and estrogen deficiency management. Globally, the demand for pharmaceutical-grade estradiol is driven by aging populations and the expanding scope of hormone therapies.

Norethindrone Acetate

Norethindrone acetate (Norethindrone) is a progestin used extensively in oral contraceptives and hormone therapy. Its role in regulating menstrual cycles and preventing pregnancy makes it a highly sought-after component in contraceptive pills. Norethindrone acetate also plays a role in managing endometrial hyperplasia and abnormal uterine bleeding.


Leading Suppliers of Estradiol and Norethindrone Acetate

1. Merck KGaA (EMD Serono)

Overview

A global leader in pharmaceutical ingredients, Merck KGaA’s division EMD Serono supplies high-quality hormone active pharmaceutical ingredients (APIs). Their estradiol is widely used across generic and proprietary formulations.

Capabilities

  • Robust manufacturing infrastructure ensuring batch consistency.
  • cGMP-compliant facilities.
  • Proven track record with regulatory agencies like the FDA, EMA.

Product Portfolio

  • Pharmaceutically pure estradiol for oral, topical, and injectable applications.
  • Norethindrone acetate with high bioavailability and stability.

2. Bayer AG

Overview

Bayer is a major player in hormonal APIs, providing both estradiol and norethindrone acetate to multinational pharmaceutical companies.

Capabilities

  • Extensive R&D for formulation enhancements.
  • Established global distribution network.
  • Commitment to quality and regulatory compliance.

Product Portfolio

  • Estradiol APIs suitable for HRT products.
  • Norethindrone acetate raw materials adhering to pharmacopeial standards.

3. Xian Frontal Pharma Co., Ltd.

Overview

A Chinese-based manufacturer specializing in steroid hormones, including estradiol and norethindrone acetate. They are known for cost-effective high-volume production.

Capabilities

  • Competitive pricing, making them attractive for generics manufacturers.
  • ISO and cGMP certifications.
  • Export capacity to North America, Europe, Asia.

Product Portfolio

  • Pharmaceutical-grade estradiol with certifications for regulatory submission.
  • Norethindrone acetate complying with USP, EP standards.

4. Jiangsu Hengrui Medicine Co., Ltd.

Overview

A leading Chinese pharmaceutical company with a broad portfolio of hormones, including estradiol and norethindrone acetate.

Capabilities

  • Extensive clinical development and manufacturing expertise.
  • Focused on quality assurance and regulatory approval facilitation.

Product Portfolio

  • High-purity APIs for formulated hormone therapies.
  • Custom synthesis options.

5. Piramal Pharma Solutions

Overview

A reputed contract development and manufacturing organization (CDMO) with capabilities in hormone APIs, including estradiol and norethindrone acetate.

Capabilities

  • Specialty manufacturing with tailored production processes.
  • Extensive regulatory experience.

Product Portfolio

  • Pharmaceutical-grade APIs suitable for solid and liquid formulations.
  • Stringent quality control standards.

6. Watson Pharmaceuticals (now part of Mylan/Biocon)

Overview

A major supplier with a long history of producing hormone APIs, including estradiol and norethindrone acetate.

Capabilities

  • Economical sourcing options.
  • Global distribution channels.
  • Extensive regulatory dossiers.

Emerging Trends and Sourcing Considerations

Global Supply Chain Dynamics

The supply landscape for estradiol and norethindrone acetate is affected by geopolitical influences, manufacturing regulations, and raw material availability. Recent disruptions, such as those caused by the COVID-19 pandemic, highlighted vulnerabilities in concentrated production zones, primarily China and India. Consequently, pharmaceutical companies are diversifying sourcing strategies to mitigate risks.

Regulatory and Quality Assurance

Suppliers must comply with evolving Good Manufacturing Practice (GMP) standards and meet regulatory approvals from authorities such as the FDA, EMA, or PMDA. Certificates of Analysis (CoA), stability data, and traceability are critical for validation processes.

Cost Versus Quality

While cost competitiveness is vital, especially for generics manufacturers, regulatory compliance and API purity remain paramount for patient safety and market access. Suppliers offering cGMP-compliant APIs with comprehensive documentation are preferred.

Sustainability and Ethical Sourcing

Increasing emphasis is placed on sustainable manufacturing practices, environmental impact reduction, and ethical sourcing of raw materials. Suppliers adhering to these principles are gaining favor.


Key Factors for Selecting a Supplier

  • Regulatory Compliance: GMP certifications, recent audit reports, and regulatory approvals.
  • Product Purity: Certified potency, absence of impurities, and stability profiles.
  • Production Capacity: Ability to meet current and projected demand.
  • Reputation and Track Record: Historical performance, references, and customer feedback.
  • Cost and Lead Times: Competitive pricing balanced with reliable delivery schedules.
  • Technical Support: Availability of technical data, formulation assistance, and quality troubleshooting.

Conclusion

The procurement of high-quality estradiol and norethindrone acetate requires careful evaluation of supplier capabilities, regulatory compliance, and supply chain robustness. Leading pharmaceutical ingredient suppliers like Merck KGaA, Bayer, and prominent Chinese manufacturers such as Xian Frontal Pharma and Jiangsu Hengrui offer strong options across various markets. As the demand for hormone-based therapies expands, establishing relationships with reputable, compliant, and reliable suppliers remains critical for pharmaceutical companies aiming to maintain product quality, regulatory approval, and market competitiveness.


Key Takeaways

  • Demand for hormone APIs such as estradiol and norethindrone acetate is rising due to aging populations and contraceptive needs.
  • Global suppliers include established entities like Merck KGaA, Bayer, and regional manufacturers from China and India, offering competitive options.
  • Supplier selection should prioritize regulatory compliance, API purity, manufacturing capacity, and supply chain resilience.
  • Recent supply chain disruptions underscore the importance of diversification and sourcing from multiple qualified vendors.
  • Sustainable manufacturing practices are increasingly influencing supplier selection criteria, aligning quality with environmental and ethical standards.

FAQs

1. What are the primary regions for sourcing pharmaceutical-grade estradiol and norethindrone acetate?
North America and Europe primarily source from established global pharmaceutical companies like Merck and Bayer, while China and India are major regional suppliers offering cost-efficient options.

2. How do I verify the quality and authenticity of hormone APIs from suppliers?
Request comprehensive Certificates of Analysis, Good Manufacturing Practice (GMP) certifications, and quality audits. Regulatory dossiers and third-party testing confirm compliance and purity.

3. Are there notable differences between synthetic and natural versions of estradiol for pharmaceutical use?
Most pharmaceutical-grade estradiol is chemically synthesized to meet purity and stability standards, with natural extraction being less common due to consistency concerns and manufacturing costs.

4. What challenges exist in sourcing norethindrone acetate globally?
Raw material availability, manufacturing capacity constraints, fluctuating regulatory demands, and geopolitical factors can affect supply stability.

5. How has COVID-19 impacted the supply chain for hormone APIs?
Disruptions in manufacturing, shipping delays, and raw material shortages have led to supply constraints, prompting companies to reassess sourcing strategies and diversify suppliers.


References

[1] "Pharmaceutical APIs Market," Global Market Insights, 2022.
[2] "Hormonal APIs: Market Dynamics," Industry Reports, 2023.
[3] "GMP Certification Standards," U.S. FDA Guidelines, 2021.
[4] "Supply Chain Disruptions in Pharmaceuticals," WHO Reports, 2022.
[5] "Regulatory Considerations for Hormone APIs," EMA Documentation, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.